Marshall Wace, LLP Applied Therapeutics Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 534,004 shares of APLT stock, worth $464,583. This represents 0.01% of its overall portfolio holdings.
Number of Shares
534,004Holding current value
$464,583% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$9.17 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$8.62 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$8.55 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$6.96 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$5.92 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $41.8M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...